Hi-Tech Pharmacal (HITK)l’s ECR Pharmaceuticals Subsidiary Launches Hylase® Wound Gel
1/18/2012 6:20:20 AM
More...
|
Elite Pharmaceuticals, Inc. (ELI) ECR Pharmaceuticals Launch Lodrane D(R) Allergy Product
9/27/2011 10:19:11 AM
More...
|
Hi-Tech Pharmacal (HITK) Acquires Rights to TussiCaps(R) Extended-Release Capsules to be Promoted by Their ECR Pharmaceuticals Subsidiary
8/25/2011 6:55:47 AM
More...
|
Hi-Tech Pharmacal (HITK) Acquires Rights to Branded Products to be Promoted by Their ECR Pharmaceuticals Subsidiary
6/28/2011 7:06:44 AM
More...
|
FDA Action Affects Products Marketed by Hi-Tech Pharmacal (HITK)’s ECR Pharmaceuticals Subsidiary
3/3/2011 10:51:17 AM
More...
|
Hi-Tech Pharmacal (HITK)'s ECR Pharmaceuticals Subsidiary to Co-Promote Unique Kidney Stone Treatment
2/16/2010 9:51:38 AM
More...
|
Hi-Tech Pharmacal (HITK) Acquires ECR Pharmaceuticals for $5.1 Million
3/2/2009 7:28:01 AM
More...
|
Elite Pharmaceuticals, Inc. (ELI) And ECR Pharmaceuticals Launch Second Once-Daily Antihistamine
12/20/2006 1:22:15 PM
More...
|
ECR Pharmaceuticals Launches LODRANE 24
10/19/2005 5:12:15 PM
More...
|